circRNA basic information
circBase ID: hsa_circ_0000231
Name: hsa_circ_ARHGAP12
Synonym: CircARHGAP12
Host Gene: ARHGAP12
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0015459
MONDO name: nasopharyngeal carcinoma
Disease details: nasopharyngeal carcinoma
Disease DO ID:
9261
Disease MeSH ID:
D00007727; D000077274
Disease NCIt ID:
C3871
Disease ICD11 ID:
1883313543
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

NPC biopsies; non-cancerous nasopharyngeal epithelial tissue samples; paraffin-embedded NPC sections; normal nasopharyngeal epithelial tissue; lung tissue

Cell lines:

NP69; 5-8F; HNE1; HNE2; HONE1; CNE2; CHE1; 6-10B; HK1; C666-1

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: EZR mRNA, EZR, TPM3, RhoA
Associated microRNA: -
Biological function: Promotes NPC cell migration, invasion, lung metastasis, filopodia extension, microfilament accumulation, EMT marker changes, and cytoskeletal remodeling.
Molecular mechanism: circARHGAP12 directly binds the EZR mRNA 3'UTR and promotes EZR mRNA stability; EZR forms a complex with TPM3 and RhoA, creating a feedback regulatory loop that drives microfilament aggregation and cytoskeletal remodeling.
Biological pathway or process:

migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); mRNA stability (promotes); other pathway/process (promotes)

Detected method:
Q
H
S
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; circRNA-seq; Actinomycin D / DRB Stability Assay; RT-qPCR; ISH (In Situ Hybridization); IHC (Immunohistochemistry); IF (Immunofluorescence); Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RIP (RNA Immunoprecipitation); RNA Pull-Down; Co-IP; Luciferase Reporter Assay; Transfection; Transwell Assay; Wound Healing Assay; In Vivo Animal Model; H&E Staining; Western Blot; Bioinformatics Analysis

Clinical significance:

circARHGAP12 may serve as a potential biomarker for NPC treatment, but its prognostic value remains unclear.

Description:

circARHGAP12 is up-regulated in nasopharyngeal carcinoma tissues and cell lines. It promotes NPC migration, invasion, lung metastasis, EMT-related changes, and cytoskeletal remodeling by directly binding the EZR mRNA 3'UTR and enhancing EZR mRNA stability, thereby activating an EZR/TPM3/RhoA feedback regulatory complex. The study suggests circARHGAP12 may be a potential biomarker and therapeutic target in NPC.

Confidence score:

0.8855

Other information
Title:

CircARHGAP12 promotes nasopharyngeal carcinoma migration and invasion via ezrin-mediated cytoskeletal remodeling.

Journal: Cancer letters
Published: 2021
PubMed ID: 32931883
Study type:

combined biological and clinical study

Data availability: PRJNA391554; GSE135083
Code availability: -